Hematology & Oncology Doctors in Carterville, IL Accepting Medicare

5 Hematology & Oncology doctors found. Showing 1 - 5

Dr. Muhammad Jawad Popalzai, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1400 Pin Oak Drive, Carterville, IL 62918 Phone: 618-985-3333    Fax: 618-985-1318

Hammad Shafqat, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1400 Pin Oak Dr, Carterville, IL 62918 Phone: 618-985-3333    Fax: 618-985-1318

Dr. Bachir Berbari, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1400 Pin Oak Dr, Carterville, IL 62918 Phone: 618-985-3333    Fax: 618-985-1318

Mrs. Lakshmi Manogna Chintalacheruvu, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1400 Pin Oak Dr, Carterville, IL 62918 Phone: 618-985-3333    Fax: 618-985-1318

Dr. John Robert Clement, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1400 Pin Oak Dr, Carterville, IL 62918 Phone: 618-985-3333    Fax: 618-985-1318

News Archive

Leading allergy organizations release report that sheds light on angioedema

With today's modern medicine, misdiagnoses may be unexpected and surprising. But when symptoms of an unknown and uncommon illness mimic a number of other conditions, it can be difficult for medical professionals to properly diagnose and treat patients. That's why four leading allergy/immunology organizations have announced the release of a report to help set a new standard for a commonly misdiagnosed, under-recognized and under treated condition known as angioedema, the rapid swelling of deep layers of skin and tissue.

Early antiretroviral treatment for people with HIV/TB coinfection could reduce mortality by half

People with HIV/tuberculosis coinfection who began antiretroviral treatment within six months of starting TB treatment had a 55% lower mortality rate than people with HIV/TB coinfection who did not begin antiretroviral therapy until after they had finished a six-month TB treatment course, according to a study conducted by researchers at the University of KwaZulu-Natal, Business Day reports (Kahn, Business Day, 9/18).

First Edition: October 1, 2013

Today's headlines detail how the federal government has been shutdown as a result of the ongoing congressional battle over the health law. Still, even as House and Senate lawmakers were unable to overcome this issue to reach a deal to provide funding to continue government operations, Oct. 1 is still the official launch of the overhaul's online insurance marketplaces.

Major investment can help improve technology aimed at turning bad fat to good fat

A significant investment from a Purdue University alumnus and his wife will help further develop technology aimed at treating obesity and diabetes by turning bad fat into good fat inside the body.

Tracerco includes award-winning radiation monitors with PEDs to meet all radiation monitoring needs

Leading industrial technology specialist Tracerco, part of the Johnson Matthey group, has added to its range of award winning radiation monitors with a family of Personal Electronic Dosimeters (PEDs), providing a solution for every radiation monitoring need.

Read more Medical News

› Verified 5 days ago